Coronary Artery Bypass Surgery Clinical Trial
Official title:
Effects of Supervised Aerobic Exercise Training on Respiratory Parameters, Exercise Capacity, and Anxiety in Patients With Coronary Artery Bypass Surgery
NCT number | NCT05188352 |
Other study ID # | BVUsozyilmaz09 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | January 2017 |
Est. completion date | July 2018 |
Verified date | December 2021 |
Source | Bezmialem Vakif University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Based on clinical experience both physical condition and psychological recovery after surgery are individually variable. Exercise training plays an important part, has been recommended for CABS patients in order to enhance recovery. Regular exercise following CABS has shown that, in addition to the expected improvements in exercise capacity as a result of the surgery itself, patients who participate in cardiac rehabilitation can expect to see additional gains in exercise capacity and risk factor profiles. Exercise training also increases personal self-esteem and self-confidence, can alleviate depression and fear, and increase the sense of well-being. The aim of this study was to examine the effects of supervised aerobic exercise training on pulmonary function, functional capacity, maximal exercise capacity, and anxiety in patients after coronary artery bypass surgery.
Status | Completed |
Enrollment | 30 |
Est. completion date | July 2018 |
Est. primary completion date | June 2018 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 35 Years to 70 Years |
Eligibility | Inclusion Criteria: - Male gender, - CABG surgery performed in the last one month, - Patients with negative exercise test (on the 30 days after discharge). Exclusion Criteria: - Valve surgery, - Perioperative myocardial infarction assessed by electrocardiographic (ECG) and creatine kinase isoenzyme changes, - Postoperative angina, diabetes mellitus, chronic renal failure, unstable angina, intermittent claudication, heart valve dysfunction (moderate or severe), severe cardiac arrhythmias, -Presence of symptoms at rest or with minimal exertion, - Chronic obstructive pulmonary disease (>70% FEV1/FVC), and - Any disorder that might influence exercise performance physically (e.g. severe back pain, history stroke). |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Bezmialem Vakif University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from baseline maximum inspiratory pressure at 8 weeks. | Change from baseline Maximum Inspiratory Pressure (MIP) at 8 weeks. Respiratory muscle strength was measured according to the portable, electronic intraoral pressure measuring device (MicroRPM, Micro Medical UK), American Thoracic Society (ATS) and European Respiratory Society (ERS) criteria. The most commonly used method for evaluating respiratory muscles is MIP measurement is a non-invasive technique. | [ Time Frame: Eight weeks ] | |
Primary | Change from baseline maximum expiratory pressure at 8 weeks | Change from baseline Maximum Expiratory Pressure (MEP) at 8 weeks. Respiratory muscle strength was measured according to the portable, electronic intraoral pressure measuring device (MicroRPM, Micro Medical UK), American Thoracic Society (ATS) and European Respiratory Society (ERS) criteria. The most commonly used method for evaluating respiratory muscles is MEP measurement is a non-invasive technique. | [ Time Frame: Eight weeks ] | |
Primary | Maximal exercise capacity | The incremantal, symptom-limited cardiopulmonary exercise test (CPET) was used to assess exercise capacity.
Symptom-limited maximal exercise test with oxygen consumption measurement (peak VO2) (Minjhard Oxycon-3) on the treadmill using a Modified Bruce protocol. |
[ Time Frame: Eight weeks ] | |
Secondary | Change from baseline distance covered in six-minute walk test at 8 weeks. | Change from baseline functional capacity test at 8 weeks. Functional capacity was assessed by the 6 minute walking test. The test was performed according to American Thoracic Society (ATS) criteria. Patients were allowed to rest for 10 minutes before the test. Heart rate, blood pressure, respiratory frequency, oxygen saturation, fatigue and dyspnea perception were recorded before and after the test. Walking distance was calculated. | [ Time Frame: Eight weeks ] | |
Secondary | Change from baseline Forced Vital Capacity (FVC) at 8 weeks | Change from baseline Forced Vital Capacity (FVC) in respiratory function test at 8 weeks. FVC was evaluated using spirometry, according to the American Thoracic Society (ATS) and European Respiratory Society (ERS) criteria. | [ Time Frame: Eight weeks ] | |
Secondary | Change from baseline Forced Expiratory Volume in 1 second (FEV1) at 8 weeks . | Change from baseline Forced Expiratory Volume 1 second (FEV1) in respiratory function at 8 weeks. FEV1 was evaluated using spirometry, according to the American Thoracic Society (ATS) and European Respiratory Society (ERS) criteria. | [ Time Frame: Eight weeks ] | |
Secondary | Change from baseline Forced Expiratory flow from between 25% to 75% of Vital Capacity at 8 weeks. | Change from baseline Forced Expiratory flow from between 25% to 75% of Vital Capacity at 8 weeks.
FMF was evaluated using spirometry, according to the American Thoracic Society (ATS) and European Respiratory Society (ERS) criteria. |
[ Time Frame: Eight weeks ] | |
Secondary | Change from baseline anxiety level at 8 weeks. | Anxiety level was evaluated by STAI-I and II. | [ Time Frame: Eight weeks ] | |
Secondary | Change from baseline maximal oxygen consumption(VO2max) level at 8 weeks | Respiratory parameters were continuously measured by using computerized 'Minjhard Oxycon-3'. Measurements were performed in each 30 second, before, during and after exercise test and during each recovery period for five minutes parameters measured. | [ Time Frame: Eight weeks ] | |
Secondary | Change from baseline maximal respiratory minute volume (VE), level at 8 weeks | Respiratory parameters were continuously measured by using computerized 'Minjhard Oxycon-3'. Measurements were performed in each 30 second, before, during and after exercise test and during each recovery period for five minutes parameters measured | [ Time Frame: Eight weeks ] | |
Secondary | Change from baseline VO2max/kg level at 8 weeks | Respiratory parameters were continuously measured by using computerized 'Minjhard Oxycon-3'. Measurements were performed in each 30 second, before, during and after exercise test and during each recovery period for five minutes parameters measured | [ Time Frame: Eight weeks ] | |
Secondary | Change from baseline maximal oxygen pulse (O2pulse) level at 8 weeks | O2 pulse value was calculated from VO2 value which was divided to (by) heart rate at that minute. | [ Time Frame: Eight weeks ] | |
Secondary | Change from baseline maximal MET level at 8 weeks | Respiratory parameters were continuously measured by using computerized 'Minjhard Oxycon-3'. Measurements were performed in each 30 second, before, during and after exercise test and during each recovery period for five minutes parameters measured | [ Time Frame: Eight weeks ] |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05139108 -
TEE Monitoring and the Incidence of Postoperative Acute Kidney Injury in Coronary Artery Bypass Grafting
|
||
Completed |
NCT04523064 -
POST-CABGDM: Empagliflozin in Perioperative CABG
|
Phase 4 | |
Not yet recruiting |
NCT05540249 -
Pre-operative Carbohydrates in Diabetic Patients Undergoing CABG
|
N/A | |
Completed |
NCT01467232 -
IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing Coronary Artery Bypass Grafting
|
Phase 2 | |
Completed |
NCT04631809 -
Computed Tomography Coronary Angiography in Patients With a Previous Coronary Artery Bypass Graft Surgery Trial
|
N/A | |
Completed |
NCT00073580 -
Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)
|
Phase 3 | |
Terminated |
NCT03346278 -
Text Message Intervention to Improve Cardiac Rehab Participation
|
N/A | |
Completed |
NCT00303641 -
Safety and Effectiveness of the Medtronic Resting Heart Bypass System in Heart Surgery Patients
|
Phase 1 | |
Completed |
NCT03823521 -
Observational Study to Investigate the Effects of Training on the Administration of Cardioplexolâ„¢
|
Phase 3 | |
Terminated |
NCT00789399 -
A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis
|
N/A | |
Completed |
NCT02592824 -
Glutamate for Metabolic Intervention in Coronary Surgery II
|
Phase 3 | |
Not yet recruiting |
NCT05079724 -
Acute Kidney Injury After Cardiac Surgery
|
||
Withdrawn |
NCT04379947 -
Preoperative Use of Fractional Flow Reserve in CABG Use and Effectiveness of FFR-based CABG in Real-life Practice
|
||
Terminated |
NCT00858936 -
Reduction of Ischemia-Reperfusion Mediated Cardiac Injury in Subjects Undergoing Coronary Artery Bypass Graft Surgery
|
Phase 2 | |
Recruiting |
NCT01386229 -
A Comparison of Etomidate and Ketamine for Anesthesia Induction in Coronary Artery Bypass Graft Surgery
|
Phase 4 | |
Completed |
NCT00653042 -
Clinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014 / NAPA
|
Phase 2 | |
Completed |
NCT00318227 -
Randomized Trial of a Liberal Versus a Restrictive Transfusion Strategy in Elderly Cardiac Surgery Patients
|
N/A | |
Completed |
NCT00372671 -
Evaluation of an Introductory Videotape Intervention to Improve Cardiac Rehabilitation Participation
|
Phase 3 | |
Completed |
NCT00209521 -
Comparison of AQUAVAN® Injection to DISOPRIVAN® Injectable Emulsion for Anesthesia During Coronary Artery Surgery
|
Phase 2 | |
Not yet recruiting |
NCT05396690 -
Safety and Efficacy of Remimazolam in OPCAB Surgery
|
N/A |